1 / 3
google
Article details
- Package size
- 60
- Selling units
- 60
- Measure
- g
- Galenic form
- Gel
- Galenic group
- Salben
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
160.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.1757 G | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.0001 G | Substance | HBESI |
Reimbursement information
Public price
CHF 1689.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2023
Authorization holder
RECORDATI AG
4057 Basel
Authorization information
- Swissmedic authorization number
- 67615
- Drug name
- Ledaga, Gel
- Galenic form
- GELK
- ATC Code
- L01AA05
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 28/09/2021
- Authorization expiration date
- 27/09/2026
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- LEDAGA gel 160 mcg/g tb 60 g
- Description (DE)
- LEDAGA Gel 160 mcg/g Tb 60 g
- Market launch
- 28/09/2021
- Narcotic (BTM)
- No